Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117271) titled 'A Prospective Phase II Clinical Study of First-Line Chemoradiotherapy Combined with Immunomodulatory Radiotherapy for Extensive-Stage Small Cell Lung Cancer' on Jan. 21.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Cancer Hospital Chinese Academy of Medical Sciences
Condition:
Small cell lung cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-30
Target Sample Size: Treatment group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=305090
Disclaimer: Curated by HT Syndication....